Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Selective TNFR1 blockade is anti-inflammatory and reveals an immunoregulatory role for TNFR2.

McCann FE, Perocheau DP, Ruspi G, Blazek K, Davies ML, Feldmann M, Dean JL, Stoop AA, Williams RO.

Arthritis Rheumatol. 2014 Jun 25. doi: 10.1002/art.38755. [Epub ahead of print]

PMID:
24965881
[PubMed - as supplied by publisher]
2.

IRF5 is a specific marker of inflammatory macrophages in vivo.

Weiss M, Blazek K, Byrne AJ, Perocheau DP, Udalova IA.

Mediators Inflamm. 2013;2013:245804. doi: 10.1155/2013/245804. Epub 2013 Dec 23.

PMID:
24453413
[PubMed - in process]
Free PMC Article
3.

Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.

McCann FE, Palfreeman AC, Andrews M, Perocheau DP, Inglis JJ, Schafer P, Feldmann M, Williams RO, Brennan FM.

Arthritis Res Ther. 2010;12(3):R107. doi: 10.1186/ar3041. Epub 2010 Jun 2.

PMID:
20525198
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk